Cover Image

Major Depressive Disorder Rethinking and Understanding Recent Discoveries /

This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the al...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Kim, Yong-Ku. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Singapore : Springer Singapore : Imprint: Springer, 2021.
Edition:1st ed. 2021.
Series:Advances in Experimental Medicine and Biology, 1305
Subjects:
Neurosciences.
Neurobiology.
Psychopharmacology.
Online Access:https://doi.org/10.1007/978-981-33-6044-0
Table of Contents:
  • Section I. Re-thinking depression from a network perspective
  • Chapter 1. Phenotype network and brain structural covariance network of major depression
  • Chapter 2. Task MRI-based functional brain network of major depression
  • Chapter 3. White matter-based structural brain network of major depression
  • Chapter 4. The application of a machine learning-based brain MRI approach in major depression
  • Chapter 5. Resting state functional MRI in major depression
  • Chapter 6. Development of neuroimaging–based biomarkers in depressive disorder
  • Section II. Current diagnostic and neurobiological issues
  • Chapter 7. Challenges and strategies for current classifications of depressive disorders: proposal for future diagnostic standards
  • Chapter 8. Epigenetics: a missing link between early life stress and depression
  • Chapter 9. Glia- neuron communications and gut-brain axis in depression
  • Chapter 10. Apoptosis and proliferation markers in major depression
  • Chapter 11. A load to find clinically useful biomarkers for depression
  • Chapter 12. Pharmacogenomic tests for diagnosis and treatment prediction in depression
  • Section III. Current specific treatments for depression
  • Chapter 13. Biofeedback and neurofeedback for depression: a critical review
  • Chapter 14. Cognitive behavioral therapy and mindfulness based cognitive therapy for depressive disorders
  • Chapter 15. Acceptance Commitment Therapy (ACT) for major depressive disorder
  • Chapter 16. Neurostimulation therapies in depressive disorders
  • Chapter 17. Ketamine in major depression : New rapid antidepressant
  • Chapter 18. Psychodynamic therapy in depressive disorders
  • Chapter 19. Well-being therapy in depressive disorders
  • Chapter 20. Complementary and alternative medicine in the treatments of depressive disorders
  • Chapter 21. Current psychopharmacology algorithm for major depressive disorder
  • Section IV. Promising future treatments for depression
  • Chapter 22. Novel psychopharmacology for depressive disorders
  • Chapter 23. Cannabinoid agents for depressive disorders
  • Chapter 24. Virtual Reality for the treatment of depressive disorders
  • Chapter 25. Epigenetic Therapy in depressive disorders
  • Chapter 26. Induced pluripotent stem (iPS) cells technology: potential therapeutic targets for depression
  • Chapter 27. Vaccination and immunotherapy for major depression
  • Chapter 28. Psychedelic Medicines in major depression: progress and future challenges
  • Chapter 29. Precision Psychiatry: Biomarker guided Tailored Therapy for Effective Treatment and Prevention in major depression. .

Similar Items